Comparison of Initial Treatment in With Laser Grid in Diabetic Macular Edema to Intra Vitreal Avastin Injections
NCT ID: NCT01769599
Last Updated: 2013-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2013-01-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema
NCT00071773
Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema
NCT01355692
Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement
NCT01783886
Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema
NCT00069056
Intravitreal Aflibercept Injection in Vision Impairment Due to DME
NCT01331681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Grid Treatment
30 patients that were treated with laser grid treatment
No interventions assigned to this group
Avastin Treatment
patients that were treated with Avastin injections
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 30 to 80 Yrs. old
* no previous ocular treatment
* patiens with macular edema that was shown by OCT or FA
* patients with at least 6 months follow-up after the last treatment
Exclusion Criteria
* patients with previous ocular surgery
* patiens with eye trauma
* patiens with macular edema not from DM
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziv Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
yehudit.hackmon
Reaserch coordinator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziv Medical Center
Safed, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Otzem Chassid, M.D
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0108-12-ZIV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.